LIMITED-STAGE SMALL-CELL LUNG CANCER
Clinical trials for LIMITED-STAGE SMALL-CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new LIMITED-STAGE SMALL-CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for LIMITED-STAGE SMALL-CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested in aggressive lung cancer
Disease control Not yet recruitingThis study is testing whether adding a new immunotherapy drug called adebrelimab to standard chemotherapy and radiation can better control limited-stage small-cell lung cancer. It will enroll 30 patients to see if this combination is safe and effective at keeping the cancer from …
Matched conditions: LIMITED-STAGE SMALL-CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New drug aims to shield patients from Chemo's harsh side effects
Disease control Not yet recruitingThis study is testing whether a drug called trilaciclib can protect patients' bone marrow from damage during chemotherapy for a type of lung cancer. About 120 people with limited-stage small cell lung cancer will receive either trilaciclib or a placebo before their chemo. The mai…
Matched conditions: LIMITED-STAGE SMALL-CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Pharmacosmos A/S • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC